To determine whether the inhibitory effect on renal cancer cell survival by pharmacological inhibition of GSK-3 was specific to GSK-3β, we depleted GSK-3α or GSK-3β expression in ACHN cancer cells using siRNA (Figure 3E). Here, GSK3A is linked to renal carcinoma.